Entropy’s Psilocin Therapy Holds its Effect for 12 Weeks
Entropy Neurodynamics has reported sustained improvements in treatment-resistant binge-eating disorder three months after patients received two infusions of its IV ...
Entropy Neurodynamics has reported sustained improvements in treatment-resistant binge-eating disorder three months after patients received two infusions of its IV ...
Australian biotechnology company Entropy Neurodynamics (ASX: ENP) has reported encouraging topline results from the first cohort of its Phase 2 ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
